Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by 131itm601 Chlorotoxin

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • 131itm601 Chlorotoxin1

Active Sponsors

  • Istituto Europeo di Oncologia1
  • Istituto Clinico Humanitas1
  • TransMolecular1
  • Scientific Institute San Raffaele1

Top Investigators

Related Conditions

  • Melanoma1
  • Pancreatic Cancer1
  • Nonsmall Cell Lung Cancer1
  • Prostate Adenocarcinoma1
  • Glioma1

Activity Timeline